Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Miami, FL
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
St. Petersburg, FL
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Atlanta, GA
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Chicago, IL
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Avon, IN
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Avon, IN
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
New Orleans, LA
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Bangor, ME
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Bangor, ME
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Royal Oak, MI
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Royal Oak, MI
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Picayune, MS
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Picayune, MS
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Clifton, NJ
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Clifton, NJ
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Toms River, NJ
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Toms River, NJ
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Albuquerque, NM
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
New York, NY
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Springfield Gardens, NY
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Springfield Gardens, NY
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Charlotte, NC
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Shelby, NC
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Shelby, NC
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Norman, OK
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Norman, OK
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Medford, OR
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Medford, OR
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Clinton, SC
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Clinton, SC
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Kingsport, TN
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Kingsport, TN
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Dallas, TX
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Houston, TX
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
Midland, TX
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
Midland, TX
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated:  6/1/2016
mi
from
Vancouver,
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
A Randomized, Double-blind, Placebo-controlled Study to Assess the Effect of Taspoglutide on Glycemic Control, and Its Safety and Tolerability, in Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy.
Status: Enrolling
Updated: 6/1/2016
mi
from
Vancouver,
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
University of California at San Francisco
mi
from
San Francisco, CA
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Stanford Univ Med Ctr
mi
from
Stanford, CA
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Barbara Davis Center for Childhood Diabetes/ University of Colorado
mi
from
Denver, CO
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Barbara Davis Center for Childhood Diabetes/ University of Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
University of Florida
mi
from
Gainesville, FL
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
University of Miami School of Medicine
mi
from
Miami, FL
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
University of Miami School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Riley Hospital for Children, Indiana University
mi
from
Indianapolis, IN
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Riley Hospital for Children, Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Joslin Diabetes Center, Children's Hospital Boston
mi
from
Boston, MA
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Joslin Diabetes Center, Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Naomi Berrie Diabetes Center (Columbia University)
mi
from
New York, NY
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Naomi Berrie Diabetes Center (Columbia University)
mi
from
New York, NY
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
University of Texas Medical Center at Dallas
mi
from
Dallas, TX
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
University of Texas Medical Center at Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Benaroya Research Institute
mi
from
Seattle, WA
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Benaroya Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated:  6/1/2016
Walter and Eliza Hall Institute of Medical Research
mi
from
Parkville,
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Status: Enrolling
Updated: 6/1/2016
Walter and Eliza Hall Institute of Medical Research
mi
from
Parkville,
Click here to add this to my saved trials
Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients
Tacrolimus and Mycophenolate Mofetil vs Tacrolimus and Sirolimus in SPK, Pancreas After Kidney or Pancreas Transplant Alone
Status: Enrolling
Updated:  6/2/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients
Tacrolimus and Mycophenolate Mofetil vs Tacrolimus and Sirolimus in SPK, Pancreas After Kidney or Pancreas Transplant Alone
Status: Enrolling
Updated: 6/2/2016
University of Miami Miller School of Medicine
mi
from
Miami, FL
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Anniston, AL
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Anniston, AL
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Mobile, AL
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Mesa, AZ
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Mesa, AZ
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Fayetteville, AR
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Jonesboro, AR
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Little Rock, AR
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Little Rock, AR
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Chino, CA
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Corona, CA
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Corona, CA
Click here to add this to my saved trials
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated:  6/7/2016
Clinical Research Facility
mi
from
Fountain Valley, CA
Study of a Topical Gentamicin-Collagen Sponge Along With Systemic Antibiotic in Infected Diabetic Foot Ulcers
A Phase 3 Randomized, Placebo-Controlled, Blinded Study to Investigate the Safety and Efficacy of a Topical Gentamicin-Collagen Sponge in Combination With Systemic Antibiotic Therapy in Diabetic Patients With an Infected Foot Ulcer
Status: Enrolling
Updated: 6/7/2016
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials